Rialto Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Rialto Wealth Management's DNA Position: Q3 2026 in Review
Rialto Wealth Management sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 49 shares — an estimated $486 sold.
Rialto Wealth Management first reported a position in DNA in Q1 2026 and held it in 2 quarters. The position peaked at $486 in Q2 2026. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Rialto Wealth Management reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
- Rialto Wealth Management sold 49 Ginkgo Bioworks shares in Q3 2026, an estimated $486.
- Rialto Wealth Management first reported a position in Ginkgo Bioworks in Q1 2026 and held it in 2 quarters.
- Rialto Wealth Management's Ginkgo Bioworks position peaked at $486 in Q2 2026.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.